The Cooper Companies, Inc.
COO
Rank in Stocks
#1935
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Share Price
$57.50
Last synced: 2026-10-16
Market Cap
$10.93B
Change (1 day)
0.17%
Change (1 year)
-20.11%
Country
US
Trade The Cooper Companies, Inc. (COO)
Category
Healthcare
EPS for The Cooper Companies, Inc. (COO)
EPS as of July 2026 TTM: $2.93
According to The Cooper Companies, Inc. latest financial reports and stock price the company's current EPS (TTM) is $2.93. At the end of 2024 the company had a EPS of $1.97 an increase over its 2023 EPS that were of $1.49.
EPS history for The Cooper Companies, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $2.93 | 55.85% |
| 2025 | $1.88 | -4.57% |
| 2024 | $1.97 | 32.21% |
| 2023 | $1.49 | -23.98% |
| 2022 | $1.96 | -96.72% |
| 2021 | $59.73 | 1,129.01% |
| 2020 | $4.86 | -48.68% |
| 2019 | $9.47 | 232.28% |
| 2018 | $2.85 | -62.65% |
| 2017 | $7.63 | 35.04% |
| 2016 | $5.65 | 34.52% |
| 2015 | $4.20 | -25.13% |
| 2014 | $5.61 | -7.88% |
| 2013 | $6.09 | 17.57% |
| 2012 | $5.18 | 38.50% |
| 2011 | $3.74 | 50.81% |
| 2010 | $2.48 | 11.21% |
| 2009 | $2.23 | 52.74% |
| 2008 | $1.46 | -684.00% |
| 2007 | $-0.25 | -116.78% |
| 2006 | $1.49 | -27.67% |
| 2005 | $2.06 | -27.21% |
| 2004 | $2.83 | 28.64% |
| 2003 | $2.20 | 37.50% |
| 2002 | $1.60 | 28.00% |
| 2001 | $1.25 | 22.55% |
| 2000 | $1.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.85 | 202.05% |
US
|
|
| $6.41 | 118.61% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 13.31% |
US
|
|
| - | - |
CH
|
